Mười câu hỏi và mười câu trả lời để làm rõ “hộp đen” của nhà tạo lập thị trường: Tại sao các nhà đầu tư mạo hiểm lại tham gia vào hoạt động tạo lập thị trường? Liệu chủ dự án có thực sự dễ bị đâm sau lưng không?

Genomic Health

company

About

Genomic Health is a provider of genomic-based diagnostic tests that address overtreatment and optimal treatment of early-stage cancer.

  • 501 - 1000

Details

Industries
Biotechnology,Genetics,Health Care,Pharmaceutical
Founded date
Jan 1, 2000
Number Of Employee
501 - 1000
Operating Status
Active

Genomic Health, Inc. (NASDAQ: GHDX) is a provider of genomic-based diagnostic tests that address both the overtreatment and optimal treatment of early-stage cancer, one of the greatest issues in healthcare today. The company is applying its world-class scientific and commercial expertise and infrastructure to lead the translation of massive amounts of genomic data into clinically-actionable results for treatment planning throughout the cancer patient's journey, from diagnosis to treatment selection and monitoring. The company is based in Redwood City, California, with European headquarters in Geneva, Switzerland.

Investments

Number of Investments
Number of Lead Investments
3
1
Genomic Health has made 3 investments. Their most recent investment was on Nov 28, 2017, when Cleveland Diagnostics raised $2M.
Date Company Name
Round Money Raised Industry Lead Investor
Convertable Note $2M Biotechnology Yes
Oct 13, 2014 Invitae
Series F $120M Biotechnology
Dec 10, 2013 Invitae
Series E $40M Biotechnology